Becton Dickinson & Co (WBO:BDX)
€ 210.4 -0.6 (-0.28%) Market Cap: 60.75 Bil Enterprise Value: 77.74 Bil PE Ratio: 37.36 PB Ratio: 2.48 GF Score: 82/100

Becton Dickinson and Co at Evercore ISI HealthCONx Conference Transcript

Nov 28, 2023 / 01:20PM GMT
Release Date Price: €217.5 (-0.68%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team

Great. Thanks, everyone, for joining us this morning. I'm Vijay Kumar, the med tech and life science tools analyst at Evercore. It's a pleasure to have with us Becton, Dickinson. Representing the company, we have Rick Byrd, EVP, President of BD Interventional and the CFO, Chris DelOrefice.

Chris and Rick, thank you both for joining us this morning.

Christopher J. DelOrefice
Becton, Dickinson and Company - Executive VP & CFO

Yes, thanks for having, good to be here.

Questions & Answers

Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team

Fantastic. So Chris, maybe I'm going to start off with you. When I look at your Q4 stock reaction, it's a pretty unusual reaction for BD. General view is BD is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot